Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Genicular nerve blocks provide short term pain relief for patients with knee osteoarthritis

Results from a recent clinical trial published by Wiley in Arthritis & Rheumatology demonstrate that patients with knee osteoarthritis experience short term pain relief from genicular nerve blocks-;or locally injected anesthetics that block nerves around the knee joint.

13 Nov 2022

Updated EULAR recommendations on the use of DMARDs for people with RA

Since their first publication in 2010, the EULAR recommendations for the use of disease-modifying anti-rheumatic treatments (DMARDs) in people with RA have become a most important publication in the field, and their updates are relied upon by many healthcare professionals, professional organizations and other stakeholders to offer an up-to-date and robust analysis on an optimal approach to the application of available treatment options in clinical practice.

11 Nov 2022

Magnetic resonance imaging can reliably establish measurements for ACL footprint

Magnetic resonance imaging (MRI) can reliably establish measurements for anterior cruciate ligament (ACL) "footprints" that are critical to the placement of grafts for reconstruction surgery, UT Southwestern researchers report.

10 Nov 2022

People with long covid face barriers to government disability benefits

When Josephine Cabrera Taveras was infected with covid-19 in spring 2020, she didn't anticipate that the virus would knock her out of work for two years and put her family at risk for eviction.

9 Nov 2022

Higher dose of pneumococcal vaccine improves antibody response in patients receiving rituximab for ANCA-associated vasculitis

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, showed that a higher dose of pneumococcal vaccine safely and effectively improved antibody response in patients receiving rituximab for ANCA-associated vasculitis.

8 Nov 2022

Skipping methotrexate for one week after flu vaccine provides the same seroprotection as a two-week hold in RA patients

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, showed that discontinuing methotrexate for one week after seasonal influenza vaccination provided the same seroprotection as a two-week discontinuation period in patients with rheumatoid arthritis.

8 Nov 2022

Combination treatment does not slow radiographic spinal progression in radiographic axSpA patients

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, showed that combining a nonsteroidal anti-inflammatory drug and TNF inhibitor did not significantly slow radiographic spinal progression in radiographic axial spondyloarthritis patients.

8 Nov 2022

Lower hydroxychloroquine dosing results in increased SLE-related hospitalizations, study finds

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual scientific meeting, found that the recommended weight-based or non-weight-based dose of hydroxychloroquine led to more hospitalizations for flares among patients with systemic lupus erythematosus

8 Nov 2022

Spine disease in CRMO patients found to be more common than previously believed

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, shows that spine disease, once considered a rarity in chronic recurrent multifocal osteomyelitis, affects as many as 10-35% of patients and is asymptomatic in one-third.

8 Nov 2022

Study: No significant difference in cancer risk in rheumatology patients with history of malignancy taking DMARDs

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found no significant difference in cancer risk in patients with rheumatic disease and a history of malignancy taking biologic or targeted synthetic DMARDs compared to those treated with TNF inhibitors.

8 Nov 2022

Rheumatoid arthritis patients taking opioids have twice the risk of venous thromboembolism

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found that adult RA patients starting opioids had twice the risk of venous thromboembolism (VTE) compared to patients starting nonsteroidal anti-inflammatory drugs (NSAIDs).

8 Nov 2022

Most echocardiography screenings for fetal congenital heart block fail to follow guidelines

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found that most echocardiography screening for fetal congenital heart block in anti-Ro- and anti-La-positive pregnancies did not follow recommended guidelines in one academic medical center.

8 Nov 2022

Defense department health plan cuts its pharmacy network by nearly 15,000 outlets

Doris Spatz takes a once-a-day pill, Kisqali, to keep her metastatic breast cancer in check. As a patient in the Defense Department health system, she can fill routine prescriptions at a military pharmacy without a copay but also has the option of using a regular pharmacy through Tricare, the Defense Department's private health care program.

8 Nov 2022

ACR releases new guideline that offers recommendations for integrative approach to RA treatment

The American College of Rheumatology (ACR) released a summary of its new guideline for Exercise, Rehabilitation, Diet and Additional Integrative Interventions for Rheumatoid Arthritis.

7 Nov 2022

Study estimates the quality of care for patients with long-term health conditions

The number of new diagnoses of rheumatoid arthritis fell by 20% in the first year of the COVID-19 pandemic, new research suggests.

4 Nov 2022

Novel platform allowing universal off-the-shelf T and NK cell access shows potential for immunotherapies

Recent advances in immunotherapy for cancer have stimulated a plethora of studies aimed at developing T cells (white blood cells) and Natural Killer (NK) cells (immune cells with enzymes that can kill tumor cells or cells infected with a virus) in-vitro from pluripotent stem cells-;cells that are able to self-renew by dividing and developing into the three primary groups of cells that make up a human body.

3 Nov 2022

EULAR points-to-consider can guide diagnostic evaluation, treatment and monitoring of SAIDs

SAIDs are a group of multi-system disorders caused by dysfunction in the innate immune system. A number of these SAIDs are mediated by a cytokine called interleukin-1 (IL-1), including the cryopyrin-associated periodic syndromes (CAPS), tumor necrosis factor receptor-associated periodic syndrome (TRAPS), mevalonate kinase deficiency (MKD), and deficiency of the IL-1 receptor antagonist (DIRA).

1 Nov 2022

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Genicular nerve blocks provide short term pain relief for patients with knee osteoarthritis

Updated EULAR recommendations on the use of DMARDs for people with RA

Magnetic resonance imaging can reliably establish measurements for ACL footprint

People with long covid face barriers to government disability benefits

Higher dose of pneumococcal vaccine improves antibody response in patients receiving rituximab for ANCA-associated vasculitis

Skipping methotrexate for one week after flu vaccine provides the same seroprotection as a two-week hold in RA patients

Combination treatment does not slow radiographic spinal progression in radiographic axSpA patients

Lower hydroxychloroquine dosing results in increased SLE-related hospitalizations, study finds

Spine disease in CRMO patients found to be more common than previously believed

Study: No significant difference in cancer risk in rheumatology patients with history of malignancy taking DMARDs

Rheumatoid arthritis patients taking opioids have twice the risk of venous thromboembolism

Most echocardiography screenings for fetal congenital heart block fail to follow guidelines

Defense department health plan cuts its pharmacy network by nearly 15,000 outlets

ACR releases new guideline that offers recommendations for integrative approach to RA treatment

Study estimates the quality of care for patients with long-term health conditions

Novel platform allowing universal off-the-shelf T and NK cell access shows potential for immunotherapies

EULAR points-to-consider can guide diagnostic evaluation, treatment and monitoring of SAIDs

Dietary components do not have impact on RMD outcomes

Standarized PedMSUS courses to help evaluate children with arthritis

First guidance to optimize the use of PROMs for young people with inflammatory arthritis

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in